1. Home
  2. MAGN vs THTX Comparison

MAGN vs THTX Comparison

Compare MAGN & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAGN
  • THTX
  • Stock Information
  • Founded
  • MAGN 1864
  • THTX 1993
  • Country
  • MAGN United States
  • THTX Canada
  • Employees
  • MAGN N/A
  • THTX N/A
  • Industry
  • MAGN Paper
  • THTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAGN Basic Materials
  • THTX Health Care
  • Exchange
  • MAGN Nasdaq
  • THTX Nasdaq
  • Market Cap
  • MAGN 67.4M
  • THTX 54.3M
  • IPO Year
  • MAGN N/A
  • THTX N/A
  • Fundamental
  • Price
  • MAGN $19.23
  • THTX $1.78
  • Analyst Decision
  • MAGN
  • THTX Hold
  • Analyst Count
  • MAGN 0
  • THTX 1
  • Target Price
  • MAGN N/A
  • THTX N/A
  • AVG Volume (30 Days)
  • MAGN 726.5K
  • THTX 85.1K
  • Earning Date
  • MAGN 01-01-0001
  • THTX 10-10-2024
  • Dividend Yield
  • MAGN N/A
  • THTX N/A
  • EPS Growth
  • MAGN N/A
  • THTX N/A
  • EPS
  • MAGN N/A
  • THTX N/A
  • Revenue
  • MAGN $2,175,000,000.00
  • THTX $84,316,000.00
  • Revenue This Year
  • MAGN N/A
  • THTX $5.60
  • Revenue Next Year
  • MAGN N/A
  • THTX $4.62
  • P/E Ratio
  • MAGN $31.62
  • THTX N/A
  • Revenue Growth
  • MAGN N/A
  • THTX 5.75
  • 52 Week Low
  • MAGN $15.86
  • THTX $1.08
  • 52 Week High
  • MAGN $35.23
  • THTX $2.58
  • Technical
  • Relative Strength Index (RSI)
  • MAGN N/A
  • THTX 70.56
  • Support Level
  • MAGN N/A
  • THTX $1.40
  • Resistance Level
  • MAGN N/A
  • THTX $1.56
  • Average True Range (ATR)
  • MAGN 0.00
  • THTX 0.12
  • MACD
  • MAGN 0.00
  • THTX 0.03
  • Stochastic Oscillator
  • MAGN 0.00
  • THTX 96.65

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Share on Social Networks: